Skip to content

H.Res. 1079 · 119th Congress (2025–2027)

Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.

This resolution recognizes that Charcot-Marie-Tooth (CMT) disease is significant and expresses the sense that CMT should receive robust funding for research. CMT disease is a neurological disorder that causes damage to the peripheral nerves.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.Res. 1079’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Josh Gottheimer (D-NJ-5)
Cosponsors
1 cosponsor

1 original · 0 later

  1. Rep. Don Bacon (R-NE-2)· Original · Feb 25, 2026
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Submitted in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Feb 25, 2026

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (1)
  1. Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.

    Official title, Display title · Introduced in House